glp-1 intracranial hypertension Novel use of receptor agonist therapy for pediatric idiopathic hypertension: a case report GLP-1 medications and pseudotumor cerebri

This can be especially beneficial for individuals with fair skin or those looking to maintain color year-round without relying heavily on UV exposure

Losing too much muscle while taking a GLP-1 medication can result in decreased strength, slower metabolism, increased risk of falls, and a higher likelihood of regaining weight once you stop taking the medication

The STEP trials showed semaglutide users lost an average of 12-18% of body weight over 68 weeks, with benefits observed regardless of baseline metabolic health or age

The plan is to offer patients a long-term extension period for their trials, giving whoever receives the placebo a chance to then switch and take the experimental drug

For a 5 mg vial, 2.5 mL water produces 2 mg/mL concentration